Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Theede

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Inflammatory Bowel Diseases|February 27, 2016
Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
European Journal of Gastroenterology & Hepatology|July 6, 2018
Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's diseaseSandra Bohn Thomsen, Marianne Kiszka-Kanowitz, Klaus Theede, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2015
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
Practical Laboratory Medicine|December 14, 2017
Point of care testing of fecal calprotectin as a substitute for routine laboratory analysisJulie Hejl, Klaus Theede, Brian Møllgren, et al.
Danish Medical Journal|June 8, 2013
Biologic therapy in inflammatory bowel diseaseKlaus Theede, Jens Frederik Dahlerup, Jan Fallingborg, et al.
Danish Medical Journal|July 5, 2012
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatmentInge Nordgaard-Lassen, Jens Frederik Dahlerup, Erika Belard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2025
Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn's Disease: A Copenhagen IBD Cohort StudyGorm Roager Madsen, Mohamed Attauabi, Johan F K F Ilvemark, et al.
United European Gastroenterology Journal|March 28, 2020
Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort studySandra Bohn Thomsen, Kristine Højgaard Allin, Johan Burisch, et al.
Gut Pathogens|April 9, 2025
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn's disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trialIda Marie Bruun Grønbæk, Sofie Ingdam Halkjær, Sarah Mollerup, et al.
Journal of Crohn'S & Colitis|March 4, 2025
Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis-a Copenhagen IBD Cohort StudyGorm Roager Madsen, Rune Wilkens, Mohamed Attauabi, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Inflammatory Bowel Diseases|February 27, 2016
Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
European Journal of Gastroenterology & Hepatology|July 6, 2018
Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's diseaseSandra Bohn Thomsen, Marianne Kiszka-Kanowitz, Klaus Theede, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2015
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative ColitisKlaus Theede, Susanne Holck, Per Ibsen, et al.
Practical Laboratory Medicine|December 14, 2017
Point of care testing of fecal calprotectin as a substitute for routine laboratory analysisJulie Hejl, Klaus Theede, Brian Møllgren, et al.
Danish Medical Journal|June 8, 2013
Biologic therapy in inflammatory bowel diseaseKlaus Theede, Jens Frederik Dahlerup, Jan Fallingborg, et al.
Danish Medical Journal|July 5, 2012
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatmentInge Nordgaard-Lassen, Jens Frederik Dahlerup, Erika Belard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2025
Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn's Disease: A Copenhagen IBD Cohort StudyGorm Roager Madsen, Mohamed Attauabi, Johan F K F Ilvemark, et al.
United European Gastroenterology Journal|March 28, 2020
Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort studySandra Bohn Thomsen, Kristine Højgaard Allin, Johan Burisch, et al.
Gut Pathogens|April 9, 2025
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn's disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trialIda Marie Bruun Grønbæk, Sofie Ingdam Halkjær, Sarah Mollerup, et al.
Journal of Crohn'S & Colitis|March 4, 2025
Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis-a Copenhagen IBD Cohort StudyGorm Roager Madsen, Rune Wilkens, Mohamed Attauabi, et al.
Pageof 3